Search research articles
Contact Us
Filters
Showing results (1-10 of 111) with videos related to
Page
of 12
Sort By:
Protein and Peptide Letters
|
February 25, 2014
Pharmacology of cyclic peptides: vancomycin and oxytocin as paradigms
Johannes Schulze
JAMA
|
November 18, 2010
Risk of kava hepatotoxicity and the FDA consumer advisory
Rolf Teschke, Johannes Schulze
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
July 2, 2020
[German Family Practitioners' Attitude toward the Legal and Economic Framework of their Professional Work]
Nina Berensmeier, Johannes Schulze
Drug Safety
|
August 18, 2012
Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia
Rolf Teschke, Johannes Schulze
Biomolecules
|
July 2, 2021
Cannabinoid Activity-Is There a Causal Connection to Spasmolysis in Clinical Studies?
Daniel Joseph, Johannes Schulze
Journal of Hepatology
|
April 19, 2012
Statin hepatotoxicity and the dilemma of causality in rare hepatic adverse drug reactions
Johannes Schulze, Xaver Glass
Hepatobiliary Surgery and Nutrition
|
May 16, 2017
Green tea and the question of reduced liver cancer risk: the dawn of potential clinical relevance?
Rolf Teschke, Johannes Schulze
Thorax
|
January 31, 2023
Elucidating minimal important difference in childhood interstitial lung diseases
Silvija-Pera Jerkic, Johannes Schulze
Regulatory Toxicology and Pharmacology : RTP
|
September 7, 2011
Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports
Rolf Teschke, Xaver Glass, Johannes Schulze
Zeitschrift Fur Orthopadie Und Unfallchirurgie
|
November 28, 2018
An Opinion Survey of Orthopaedic and Traumatology Surgeons Working in Outpatient Care (Society, Laws and Patients)
Ehsan Omari, Wolfgang Thoma, Johannes Schulze
Page
of 12
Search research articles
Search
Showing results (1-10 of 111) with videos related to
Sort By:
Page
of 12
Protein and Peptide Letters
|
February 25, 2014
Pharmacology of cyclic peptides: vancomycin and oxytocin as paradigms
Johannes Schulze
JAMA
|
November 18, 2010
Risk of kava hepatotoxicity and the FDA consumer advisory
Rolf Teschke, Johannes Schulze
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
July 2, 2020
[German Family Practitioners' Attitude toward the Legal and Economic Framework of their Professional Work]
Nina Berensmeier, Johannes Schulze
Drug Safety
|
August 18, 2012
Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia
Rolf Teschke, Johannes Schulze
Biomolecules
|
July 2, 2021
Cannabinoid Activity-Is There a Causal Connection to Spasmolysis in Clinical Studies?
Daniel Joseph, Johannes Schulze
Journal of Hepatology
|
April 19, 2012
Statin hepatotoxicity and the dilemma of causality in rare hepatic adverse drug reactions
Johannes Schulze, Xaver Glass
Hepatobiliary Surgery and Nutrition
|
May 16, 2017
Green tea and the question of reduced liver cancer risk: the dawn of potential clinical relevance?
Rolf Teschke, Johannes Schulze
Thorax
|
January 31, 2023
Elucidating minimal important difference in childhood interstitial lung diseases
Silvija-Pera Jerkic, Johannes Schulze
Regulatory Toxicology and Pharmacology : RTP
|
September 7, 2011
Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports
Rolf Teschke, Xaver Glass, Johannes Schulze
Zeitschrift Fur Orthopadie Und Unfallchirurgie
|
November 28, 2018
An Opinion Survey of Orthopaedic and Traumatology Surgeons Working in Outpatient Care (Society, Laws and Patients)
Ehsan Omari, Wolfgang Thoma, Johannes Schulze
Page
of 12